3-[2-[[4-[6-[(4-bromo-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazol-5-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol

C31H32BrFN6O4 — CID 174108913

IUPAC3-[2-[[4-[6-[(4-bromo-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazol-5-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol
SMILESOC1N=C(c2ccc3nc(CN4CCC(c5cccc(OCc6ccc(Br)cc6F)n5)CC4)n(C[C@@H]4CCO4)c3c2)NO1
InChIInChI=1S/C31H32BrFN6O4/c32-22-6-4-21(24(33)15-22)18-42-29-3-1-2-25(35-29)19-8-11-38(12-9-19)17-28-34-26-7-5-20(30-36-31(40)43-37-30)14-27(26)39(28)16-23-10-13-41-23/h1-7,14-15,19,23,31,40H,8-13,16-18H2,(H,36,37)/t23-,31?/m0/s1
InChIKeyZBNGJXRZHANBNM-YNBNEFOKSA-N
MW651.54 g/mol
LogP4.64
Rot. Bonds9

About 3-[2-[[4-[6-[(4-bromo-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazol-5-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol

3-[2-[[4-[6-[(4-bromo-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazol-5-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol (PubChem CID 174108913) has the molecular formula C31H32BrFN6O4 and a molecular weight of 651.54 g/mol. Its IUPAC name is 3-[2-[[4-[6-[(4-bromo-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazol-5-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol.

Molecular Properties

Compound Name3-[2-[[4-[6-[(4-bromo-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazol-5-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol
PubChem CID174108913
Molecular FormulaC31H32BrFN6O4
Molecular Weight651.54 g/mol
Exact Mass650.17
IUPAC Name3-[2-[[4-[6-[(4-bromo-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazol-5-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol
SMILESOC1N=C(c2ccc3nc(CN4CCC(c5cccc(OCc6ccc(Br)cc6F)n5)CC4)n(C[C@@H]4CCO4)c3c2)NO1
InChIInChI=1S/C31H32BrFN6O4/c32-22-6-4-21(24(33)15-22)18-42-29-3-1-2-25(35-29)19-8-11-38(12-9-19)17-28-34-26-7-5-20(30-36-31(40)43-37-30)14-27(26)39(28)16-23-10-13-41-23/h1-7,14-15,19,23,31,40H,8-13,16-18H2,(H,36,37)/t23-,31?/m0/s1
InChIKeyZBNGJXRZHANBNM-YNBNEFOKSA-N
XLogP4.64
TPSA106.26 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds9
Heavy Atoms43
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500651.54
LogP ≤ 54.64
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Analyze 3-[2-[[4-[6-[(4-bromo-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazol-5-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[2-[[4-[6-[(4-bromo-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazol-5-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol?
The IUPAC name of 3-[2-[[4-[6-[(4-bromo-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazol-5-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol (CID 174108913) is 3-[2-[[4-[6-[(4-bromo-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazol-5-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol.
What is the SMILES notation for 3-[2-[[4-[6-[(4-bromo-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazol-5-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol?
The canonical SMILES for 3-[2-[[4-[6-[(4-bromo-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazol-5-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol is OC1N=C(c2ccc3nc(CN4CCC(c5cccc(OCc6ccc(Br)cc6F)n5)CC4)n(C[C@@H]4CCO4)c3c2)NO1.
What is the InChIKey of 3-[2-[[4-[6-[(4-bromo-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazol-5-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol?
The InChIKey is ZBNGJXRZHANBNM-YNBNEFOKSA-N. The full InChI is InChI=1S/C31H32BrFN6O4/c32-22-6-4-21(24(33)15-22)18-42-29-3-1-2-25(35-29)19-8-11-38(12-9-19)17-28-34-26-7-5-20(30-36-31(40)43-37-30)14-27(26)39(28)16-23-10-13-41-23/h1-7,14-15,19,23,31,40H,8-13,16-18H2,(H,36,37)/t23-,31?/m0/s1.
What are the key properties of 3-[2-[[4-[6-[(4-bromo-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazol-5-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol?
3-[2-[[4-[6-[(4-bromo-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazol-5-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol has a molecular weight of 651.54 g/mol, XLogP of 4.64, 9 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[2-[[4-[6-[(4-bromo-2-fluorophenyl)methoxy]-2-pyridinyl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazol-5-yl]-2,5-dihydro-1,2,4-oxadiazol-5-ol is sourced from PubChem (CID 174108913), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).